INTERIM ANALYSIS DATA FROM PHASE 2 STUDY ON EFFICACY, SAFETY & INTRATUMORAL PHARMACOKINETICS OF ORAL SELINEXOR (KPT-330) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)

被引：0

作者：

Lassman, A. B. ^{[1
,2
]}

Bent, M. J. V. D. ^{[3
]}

Wen, P. Y. ^{[4
]}

Walenkamp, A. ^{[5
]}

Plotkin, S. ^{[6
]}

Kung, A. ^{[7
]}

Gardner, H. ^{[8
]}

Shacham, S. ^{[8
]}

Chudnovsky, A. ^{[8
]}

Mau-Sorensen, P. M. ^{[9
]}

机构：

[1] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA

[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Med Ctr, New York, NY USA

[3] Erasmus MC Daniel den Hoed Canc Ctr, Rotterdam, Netherlands

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Univ Groningen, Groningen, Netherlands

[6] Massachusetts Gen Hosp, Boston, MA 02114 USA

[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[8] Karyopharm Therapeut, Newton, MA USA

[9] Rigshosp, Dept Oncol, Phase Unit 1, Copenhagen, Denmark

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OS07.5

引用

页码：14 / 14

页数：1